Re: The Induction of Core Pluripotency Master Regulators in Cancers Defines Poor Clinical Outcomes and Treatment Resistance

No AccessJournal of UrologyUrological Survey1 Oct 2019Re: The Induction of Core Pluripotency Master Regulators in Cancers Defines Poor Clinical Outcomes and Treatment Resistance Anthony AtalaMD Anthony AtalaAnthony Atala More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000434AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Re: The Induction of Core Pluripotency Master Regulators in Cancers Defines Poor Clinical Outcomes and Treatment Resistance." The Journal of Urology, 202(4), p. 663 Suggested Reading : Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. J Urol 2010; 183: 2045. Link, Google Scholar : Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia. J Urol 2002; 168: 2431. Link, Google Scholar © 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 202Issue 4October 2019Page: 663-663 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Anthony Atala More articles by this author Expand All Advertisement PDF downloadLoading ...